Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

2.290 -0.070 (-2.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 138,744
Open 2.370
Bid (Size) 2.250 (10)
Ask (Size) 2.320 (2)
Prev. Close 2.360
Today's Range 2.220 - 2.450
52wk Range 1.720 - 8.270
Shares Outstanding 9,377,034
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
-52.3%
-52.3%
1 Month
+3.2%
+3.2%
3 Month
-6.5%
-6.5%
6 Month
-19.6%
-19.6%
1 Year
-56.8%
-56.8%

More News

Read More
Life Science Virtual Investor Forum Agenda Announced for September 18th
From Virtual Investor Conferences
Via GlobeNewswire
Get insights into the top gainers and losers of Monday's after-hours session.
Via Chartmill
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data
Via Benzinga
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Via Newsfile
Topics Regulatory Compliance
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Via Newsfile
Topics Regulatory Compliance
Here are the top movers in Tuesday's session.
Via Chartmill
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
Via Investor Brand Network
Curious about the most active stocks on Tuesday?
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Which stocks are gapping on Tuesday?
Via Chartmill
Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge
Via Benzinga
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
Via Newsfile
Which stocks are experiencing notable movement on Monday?
Via Chartmill
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise
Via Stocktwits
Crude Oil Down 2%; D.R. Horton Earnings Top Views
Via Benzinga
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
Via Benzinga
Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results
Via Benzinga
Topics Stocks
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Intellectual Property

Frequently Asked Questions

Is InMed Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, InMed Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does InMed Pharmaceuticals Inc. - Common Shares trade on?
InMed Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for InMed Pharmaceuticals Inc. - Common Shares?
The ticker symbol for InMed Pharmaceuticals Inc. - Common Shares is INM on the Nasdaq Stock Market
What is the current price of InMed Pharmaceuticals Inc. - Common Shares?
The current price of InMed Pharmaceuticals Inc. - Common Shares is 2.290
When was InMed Pharmaceuticals Inc. - Common Shares last traded?
The last trade of InMed Pharmaceuticals Inc. - Common Shares was at 09/19/25 04:00 PM ET
What is the market capitalization of InMed Pharmaceuticals Inc. - Common Shares?
The market capitalization of InMed Pharmaceuticals Inc. - Common Shares is 21.47M
How many shares of InMed Pharmaceuticals Inc. - Common Shares are outstanding?
InMed Pharmaceuticals Inc. - Common Shares has 21M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.